A detailed history of J. Stern & Co. LLP transactions in Zoetis Inc. stock. As of the latest transaction made, J. Stern & Co. LLP holds 199,953 shares of ZTS stock, worth $35.4 Million. This represents 4.16% of its overall portfolio holdings.

Number of Shares
199,953
Previous 189,147 5.71%
Holding current value
$35.4 Million
Previous $32.8 Billion 19.14%
% of portfolio
4.16%
Previous 3.9%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $1.86 Million - $2.12 Million
10,806 Added 5.71%
199,953 $39.1 Billion
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $1.09 Million - $1.34 Million
7,515 Added 4.14%
189,147 $32.8 Billion
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $28.9 Million - $34.9 Million
174,494 Added 2444.58%
181,632 $30.7 Billion
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $1.08 Million - $1.43 Million
7,138 New
7,138 $1.34 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track J. Stern & Co. LLP Portfolio

Follow J. Stern & Co. LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Stern & Co. LLP, based on Form 13F filings with the SEC.

News

Stay updated on J. Stern & Co. LLP with notifications on news.